Vir Biotechnology, Inc. (VIR)
8.86
-0.01
(-0.11%)
USD |
NASDAQ |
Nov 20, 10:11
Vir Biotechnology Free Cash Flow : -141.82M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | -141.82M |
| June 30, 2026 | -203.59M |
| March 31, 2026 | -449.64M |
| December 31, 2025 | -396.61M |
| September 30, 2025 | -460.43M |
| June 30, 2025 | -466.38M |
| March 31, 2025 | -422.14M |
| December 31, 2024 | -453.65M |
| September 30, 2024 | -473.07M |
| June 30, 2024 | -458.78M |
| March 31, 2024 | -778.97M |
| December 31, 2023 | -800.36M |
| September 30, 2023 | -668.37M |
| Date | Value |
|---|---|
| June 30, 2023 | -409.91M |
| March 31, 2023 | 928.33M |
| December 31, 2022 | 1.595B |
| September 30, 2022 | 1.567B |
| June 30, 2022 | 1.357B |
| March 31, 2022 | 555.04M |
| December 31, 2021 | -69.41M |
| September 30, 2021 | -148.52M |
| June 30, 2021 | -88.01M |
| March 31, 2021 | -237.98M |
| December 31, 2020 | -197.49M |
| September 30, 2020 | -153.44M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Moderna, Inc. | -2.044B |
| Vaxcyte, Inc. | -994.76M |
| Oncolytics Biotech, Inc. | -28.39M |
| Sangamo Therapeutics, Inc. | -90.46M |
| Sarepta Therapeutics, Inc. | 167.79M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -106.08M |
| Cash from Investing (Quarterly) | 44.56M |
| Cash from Financing (Quarterly) | 1.634M |
| Free Cash Flow Per Share (Quarterly) | -0.6269 |
| Free Cash Flow to Equity (Quarterly) | -103.62M |
| Free Cash Flow to Firm (Quarterly) | -106.12M |
| Free Cash Flow Yield | -9.45% |